• Исмаилова М.Х., Хаитбаева М.Р., Таирова М.И.
  Ташкентская Медицинская Академия, Республика Узбекистан, г. Ташкент

---

Аннотация

За последние десять лет спрос на магнитно-резонансную томографию (МРТ) заметно возрос в качестве диагностического метода, поскольку он обладает беспрецедентным потенциалом для создания контраста ткани на основе различий в свойствах ткани. Информация о структуре и функции ткани может быть получена также при сонографии. Кроме того, МСКТ исследования можно использовать в диагностике рака яичника, но только в поздних стадиях ее развития.

Калит сузлар

магнитно-резонансная томография, TNM классифика-ция рака яичников, стадирование, яичник.

Адабиёт

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer. Available via http://globocan.iarc.fr, accessed

on 01/03/2015

2. Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19(1):3–10

3. World Health Organization Classification of Tumours (2003) Pathology and genetics of tumours of the breast and female genital organs. IARC

4. Son H, Khan SM, Rahaman J, Cameron KL, Prasad-Hayes M, Chuang L et al (2011) Role of FDG PET/CT in staging of recurrent ovarian cancer. Radiographics 31(2):569–83. doi:10.1148/rg. 312105713

5. Holcomb K, Vucetic Z, Miller MC, Knapp RC (2011) Human epididymis protein 4 Offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women. Am J Obstet Gynecol 205(4):358.e1–6. doi:10.1016/j.ajog.2011. 05.017

6. Bandiera E, Romani C, Specchia C, Zanotti L, Galli C, Ruggeri G et al (2011) Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. Cancer Epidemiol Biomarkers Prev 20(12):2496–506. doi: 10.1158/1055-9965.EPI- 11-0635

7. Jeong YY, Outwater EK, Kang HK (2000) Imaging evaluation of ovarian masses. Radiographics 20(5):1445–70

8. Iyer VR, Lee SI (2010) MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol 194(2):311–21. doi:10.2214/AJR.09.3522

9. Wu Y, Peng H, Zhao X (2015) Diagnostic performance of contrastenhanced ultrasound for ovarian cancer: a meta-analysis. Ultrasound Med Biol 41(4):967–74. doi:10.1016/j.ultrasmedbio. 2014.11.018

10. Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR et al (2010) Society of Radiologists in Ultrasound. Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 26(3):121–31. doi:10.1097/ RUQ.0b013e3181f09099

11. Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N (2011) Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics 31(3):625–46. doi:10.1148/rg.313105066

12. Prakash P, Cronin CG, Blake MA (2010) Role of PET/CT in ovarian cancer. AJR Am J Roentgenol 194(6):W464–70. doi:10.2214/ AJR.09.3843

13. Chilla B, Hauser N, Singer G, Trippel M, Froehlich JM, Kubik- Huch RA (2011) Indeterminate adnexalmasses at ultrasound: effect of MRI imaging findings on diagnostic thinking and therapeutic decisions. Eur Radiol 21(6):1301–10. doi:10.1007/s00330-010- 2018-x

14. Togashi K (2003) Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol 13(Suppl 4):L87–104

15. Fujii S, Kakite S, NishiharaK, Kanasaki Y, Harada T, Kigawa J et al (2008) Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 28(5):1149–56. doi:10.1002/jmri.21575

16. Katayama M, Masui T, Kobayashi S, Ito T, Sakahara H, Nozaki A et al (2002) Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J Comput Assist Tomogr 26(2):250–6

17. Thomassin-Naggara I, Daraï E, Cuenod CA, Fournier L, Toussaint I, Marsault C et al (2009) Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 19(6):1544–52. doi:10.1007/s00330-009-1299-4

18. Bakir B, Bakan S, Tunaci M, Bakir VL, Iyibozkurt AC, Berkman S et al (2011) Diffusion-weighted imaging of solid or predominantly solid gynaecological adnexial masses: is it useful in the differential diagnosis? Br J Radiol 84(1003):600–11. doi:10.1259/bjr/ 90706205

19. Zhang P, Cui Y, Li W, Ren G, Chu C, Wu X (2012) Diagnostic accuracy of diffusion-weighted imaging with conventional MR imaging for differentiating complex solid and cystic ovarian tumors at 1.5T. World J Surg Oncol 10:237. doi:10.1186/1477-7819-10-237

20. Mohaghegh P, Rockall AG (2012) Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. Radiographics 32(6):1751–73. doi:10.1148/rg.326125520

21. Kyriazi S, Collins DJ, Morgan VA, Giles SL, de Souza NM (2010) Diffusion-weighted imaging of peritoneal disease for non invasive staging of advanced ovarian cancer. Radiographics 30(5):1269–85. doi:10.1148/rg.305105073

22. Zhao SH, Qiang JW, Zhang GF,Ma FH, Cai SQ, LiHMet al (2014) Diffusion-weightedMRimaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. Eur Radiol 24(9):2292–9. doi:10.1007/s00330-014-3236-4

23. Soher BJ, Dale BM, Merkle EM (2007) A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am 15(3):277–90

24. Lavdas I, Miquel ME, McRobbie DW, Aboagye EO (2014) Comparison between diffusion-weighted MRI (DW-MRI) at 1.5 and 3 tesla: a phantom study. JMagn Reson Imaging 40(3):682–90

 

25. Takeuchi M, Matsuzaki K, Harada M (2011) Preliminary observations and clinical value of N-acetyl resonances in ovarian tumours using in-vivo proton MR spectroscopy at 3T. Eur Radiol 21(12): 2640–6